Literature DB >> 27366690

Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy.

Yu-Jie Wu1, Xin Wei1, Man-Yi Xiao1, Wei Xiong1.   

Abstract

AIM: To evaluate the efficacy and safety of orbital decomposition (OD) surgery in combination with horse chestnut seed extract (HCSE), as compared to OD alone, in patients with thyroid-associated ophthalmopathy (TAO).
METHODS: Sixty-two orbits from 62 TAO patients were randomly assigned to OD or OD+HCSE at 1:1 ratio (31 received OD alone, 31 received OD+HCSE). Forty-two orbits from 21 healthy subjects were used as controls. Complete ophthalmic examination and color Doppler flow imaging (CDFI) were performed before surgery and 3mo post-surgery on all 62 orbits from the TAO patients. CDFI were also performed on the 42 control orbits. The effect of OD+HCSE and OD alone on TAO orbits was compared on several endpoints, including superior ophthalmic vein blood flow (SOVBF) parameters, subjective assessment, soft tissue involvement, lid retraction, diplopia, eye movement restriction, degree of exophthalmos, and intraocular pressure. The control orbits were used as reference for the SOVBF parameters.
RESULTS: OD surgery with or without HCSE improved SOVBF, symptoms and soft tissue involvement, decreased degree of exophthalmos and intraocular pressure in orbits of TAO patients. The OD+HCSE combination led to significantly better improvement of SOVBF than OD alone. The differences between the reductions of SOVBF in the two groups are 1.26 cm/s in max-volecity and 0.52 cm/s in min-volecity (P<0.0001).
CONCLUSION: SOVBF is significantly reduced in the orbits affected with TAO, indicating that congestion may be an important factor contributing to TAO pathogenesis. OD surgery improves the SOVBF, and combination of HCSE medication and OD surgery further improved venous return than OD surgery alone.

Entities:  

Keywords:  color Doppler flow imaging; horse chestnut seed extract; orbital decompression; superior orbital vein; thyroid-associated ophthalmopathy

Year:  2016        PMID: 27366690      PMCID: PMC4916145          DOI: 10.18240/ijo.2016.06.14

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease.

Authors:  Deniz Somer; Seyhan Bahar Ozkan; Hakan Ozdemir; Serhan Atilla; Meltem Fatma Söylev; Sunay Duman
Journal:  Jpn J Ophthalmol       Date:  2002 May-Jun       Impact factor: 2.447

Review 2.  The evaluation and treatment of graves ophthalmopathy.

Authors:  Marius N Stan; James A Garrity; Rebecca S Bahn
Journal:  Med Clin North Am       Date:  2012-02-22       Impact factor: 5.456

3.  Graves orbitopathy: correlation of CT and clinical findings.

Authors:  R A Nugent; R I Belkin; J M Neigel; J Rootman; W D Robertson; J Spinelli; D A Graeb
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

Review 4.  Management of Graves' ophthalmopathy: reality and perspectives.

Authors:  L Bartalena; A Pinchera; C Marcocci
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

5.  Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.

Authors:  M N Alp; A Ozgen; I Can; P Cakar; I Gunalp
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

6.  Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.

Authors:  Mário L R Monteiro; Rodrigo B S Moritz; Hélio Angotti Neto; Joseph E Benabou
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves' orbitopathy.

Authors:  Mário L R Monteiro; Hélio Angotti-Neto; Joseph E Benabou; Alberto J Betinjane
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

8.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

Review 9.  Diagnostic criteria for Graves' ophthalmopathy.

Authors:  G B Bartley; C A Gorman
Journal:  Am J Ophthalmol       Date:  1995-06       Impact factor: 5.258

10.  Diagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography.

Authors:  Mário L R Monteiro; Allan C P Gonçalves; Carla T M Silva; Janete P Moura; Carolina S Ribeiro; Eloisa M M S Gebrim
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more
  2 in total

1.  Decreased retinal microvasculature densities in pterygium.

Authors:  Feng Wang; Qian-Min Ge; Hui-Ye Shu; Xu-Lin Liao; Rong-Bin Liang; Qiu-Yu Li; Li-Juan Zhang; Gui-Ping Gao; Yi Shao
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves' ophthalmopathy patients.

Authors:  Dan Liu; Xueliang Xu; Sha Wang; Chengzhi Jiang; Xinhui Li; Jia Tan; Zhihong Deng
Journal:  Int Ophthalmol       Date:  2019-12-02       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.